SOARISING LTD

Company number 12532813 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

SOARISING LTD - Analysis Report

Company Number: 12532813

Analysis Date: 2025-07-29 12:08 UTC

Financial Health Assessment: SOARISING LTD (as of 31 March 2024)


1. Financial Health Score: D

Explanation:
The company's financial health score is graded "D" due to emerging symptoms of financial distress, particularly a negative net asset position in the most recent year. While the company has maintained operations and complied with filing requirements, the decline from positive net assets to a net liability position is a warning sign that calls for urgent remedial actions.


2. Key Vital Signs

Metric 2024 Value Interpretation
Fixed Assets £9,127 Significant reduction from prior years, indicating asset sales or write-downs.
Current Assets £4,285 Declined from previous years, suggesting reduced liquidity.
Current Liabilities £14,316 Stable but relatively high compared to liquid assets.
Net Current Assets (Working Capital) -£10,031 Negative working capital shows a liquidity crunch — "symptom of distress".
Total Assets Less Current Liabilities -£904 Negative value indicates total liabilities exceed assets — a critical warning.
Net Assets / Shareholders Funds -£904 Negative equity suggests the company is insolvent on a balance sheet basis.
Share Capital £850 Minimal; does not provide significant buffer.
Average Employees 3 Small team consistent with micro-entity status.

3. Diagnosis: What the Financial Data Reveals

  • Liquidity Stress: The most glaring symptom is the negative net current assets, meaning the company does not have enough short-term assets to cover its short-term liabilities. This is akin to a patient whose vital signs show insufficient blood flow to critical organs — a red flag for day-to-day operations.

  • Declining Asset Base: Fixed assets have nearly halved compared to prior years, indicating possible asset disposals or impairments. This could be a response to cash flow needs or operational downsizing but reduces the company's collateral base.

  • Negative Net Worth: The shift from positive net assets (£9,817 in 2023) to a negative net asset position (-£904 in 2024) indicates accumulated losses or write-downs that have eroded shareholder equity. This is comparable to a patient slipping into a critical condition where reserves are depleted.

  • Stable Liabilities but High Relative Burden: Although current liabilities remain steady, their proportion relative to assets has increased sharply, intensifying liquidity risk.

  • No Long-Term Debt: The absence of long-term liabilities suggests the company relies heavily on short-term financing, which is risky in times of cash flow volatility.

  • Small Scale of Operations: The company is micro-sized with limited staff and capital, which restricts financial flexibility.

  • Governance and Control: Controlled largely by a single entity and individual, which can be efficient but may limit external oversight or capital infusion options.


4. Recommendations: Specific Actions to Improve Financial Wellness

  • Immediate Cash Flow Management: Establish a rigorous cash flow forecast to identify timing mismatches and urgent funding gaps. Consider negotiating extended payment terms with creditors to ease short-term pressure.

  • Capital Injection: Explore options for new equity investment or shareholder loans to rebuild net asset value and improve the balance sheet — akin to administering a vital transfusion.

  • Cost Optimization: Review operational expenses critically to reduce burn rate, including possible downsizing or renegotiation of supplier contracts.

  • Asset Review: Evaluate fixed assets for potential recovery value or sale to generate liquidity, balancing short-term needs against long-term operational impact.

  • Debt Restructuring: Engage with creditors to restructure short-term liabilities or convert some debt into longer-term arrangements, improving the company’s solvency profile.

  • Financial Reporting and Monitoring: Enhance internal financial controls and reporting to detect distress signals early and implement corrective measures proactively.

  • Strategic Business Review: Reassess the business model and market positioning to identify growth opportunities or pivots that can restore profitability.


Medical Analogy Summary

SOARISING LTD currently exhibits "symptoms of financial distress" akin to a patient with impaired circulation and depleted reserves. The negative working capital and erosion of equity are warning signs of a liquidity crisis. Without timely intervention — an infusion of capital and strict cash flow management — the company risks further deterioration. However, with prompt remedial actions, there is potential for recovery and stabilization.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.